An Act To Improve Patient Access To And Savings From Generic Drugs And Biosimilars
Bill status
signed
all 5 stages cleared
Introduction
Jan 2024
Committee Review
Apr 2024
House Passage
Apr 2024
Senate Passage
Apr 2024
Signed into Law
Apr 2024
Introduced Jan 3, 2024
Signed Apr 22, 2024
Floor votes
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
19
Key actions
6
Committee
4
Apr 22, 2024
Signed into law
Signed by Governor
executive
Apr 11, 2024
Upper · Passed
FINALLY PASSED, in concurrence.
upper
Apr 10, 2024
Lower · Passed
FINALLY PASSED.
lower
Apr 3, 2024
Upper · Passed
Committee Amendment "A" (S-651) READ and ADOPTED.
upper
Apr 2, 2024
Legislature · Passed
Reported Out - OTP-AM
legislature
Jan 3, 2024
Committee
The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES.
lower
Jan 3, 2024
Upper · Passed
Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES suggested and ordered printed REFERENCE to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES Ordered sent down forthwith for concurrence
upper
1 primary · 8 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about LD 2114
Scope: ME
Hi! I can help you understand LD 2114. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline